Internal Medicine, Pulmonary Disease · Lincoln, NE
NPI
1477522464
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
8
Medicare group memberships
Hospitals
3
Hospital affiliations
1500 S 48th St Ste 800
Lincoln, NE, 68506
Phone (402) 483-8600
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
887 services
Medicare patients, 2024
352
Average age 74
Drug cost, 2024
$1.2M
924 prescriptions
Company payments, 2025
$128
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John F Trapp was code 99214 (office e&m - established), 149 times for 134 patients. In total John F Trapp billed 887 services in 34 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 149 | 134 | $87.33 | $13K |
| 71046 X-ray - Chest | Office | 80 | 62 | $23.50 | $1,880 |
| 85018 Blood Count | Office | 80 | 72 | $2.29 | $183 |
| 94729 Pulmonary Function Testing | Office | 80 | 72 | $38.88 | $3,110 |
| 94010 Pulmonary Function Testing | Office | 78 | 68 | $17.78 | $1,387 |
| 94726 Pulmonary Function Testing | Office | 68 | 66 | $39.18 | $2,664 |
| 99215 Office E&M - Established | Office | 52 | 38 | $127.25 | $6,617 |
| 94060 Pulmonary Function Testing | Office | 45 | 44 | $25.48 | $1,146 |
| 95811 Sleep Study | Facility | 45 | 38 | $89.10 | $4,009 |
| 95800 Sleep Study | Office | 36 | 36 | $26.63 | $959 |
| 71250 CT/CTA - Chest | Office | 33 | 28 | $53.81 | $1,776 |
| 95806 Sleep Study | Facility | 25 | 24 | $28.92 | $723 |
| 99213 Office E&M - Established | Office | 23 | 23 | $59.11 | $1,359 |
| 71271 CT/CTA - Chest | Office | 17 | 17 | $80.35 | $1,366 |
| 95806 Sleep Study | Office | 13 | 13 | $32.36 | $421 |
By year: 2022 $57K for 1,238 services; 2023 $49K for 959 services; 2024 $46K for 887 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85018 Blood Count | 80 | 72 | $2.29 | $183 |
Medicare prescription drug claims, 2024
In 2024, the drug John F Trapp prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 104 prescriptions and refills. In total John F Trapp wrote 924 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 104 | 123 | 34 | $2,491 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 85 | 105 | 12 | $47K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 80 | 104 | 14 | $67K |
| Azithromycin Generic | 69 | 120 | 15 | $929 |
| Symbicort Budesonide/Formoterol Fumarate | 52 | 78 | Under 11 | $18K |
| Breo Ellipta Fluticasone/Vilanterol | 51 | 72 | Under 11 | $28K |
| Montelukast Sodium Generic | 44 | 97 | 12 | $421 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 35 | 39 | Under 11 | $18K |
| Prednisone Generic | 32 | 32 | 13 | $134 |
| Sodium Oxybate Generic | 28 | 28 | Under 11 | $521K |
| Arnuity Ellipta Fluticasone Furoate | 25 | 33 | Under 11 | $7,322 |
| Spiriva Respimat Tiotropium Bromide | 23 | 27 | Under 11 | $14K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 20 | 20 | Under 11 | $13K |
| Gabapentin Generic | 19 | 25 | Under 11 | $191 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 17 | 32 | Under 11 | $4,518 |
Brand drugs: 589 claims; generic drugs: 335 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John F Trapp $128 ($128 in general payments such as food, travel and fees) from 3 companies. The largest payer was Histosonics, Inc. with $93.13.
| Company | Payments | Amount |
|---|---|---|
| Histosonics, Inc. | 1 | $93.13 |
| Amgen Inc. AMGN | 2 | $34.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.